Nesiritide |
Natrecor |
Nesiritide (Natrecor®) is a medication used to treat acutely decompensated congestive heart failure with dyspnea at rest or with minimal exertion (such as talk, eating or bathing). A brain natriueretic peptide, nesiritide works to facilitate cardiovascular fluid homeostasis through counterregulation of the renin-angiotensin-aldoesterone system, stimulating cyclic guanosine monophosphate, leading to smooth muscle cell relaxation. In simpler terms, it promotes vasodilation, natriuresis, and d ...
Wikipedia - [full article]
Nesiritide News Headlines
- Scios Announces Selection Of Independent Executive Committee And Planned Protocol Design For The ASCEND-HF Landmark International Outcomes Trial
MedicalNewsToday - Tue, 14 Nov 2006 08:00 EST
- Investigators Report New Renal, Mortality And Safety Data From NAPA Trial Of NATRECOR(R) (nesiritide)
MedicalNewsToday - Tue, 12 Sep 2006 07:00 EST
- Scios Announces International Outcomes Trial Of NATRECOR(R) (nesiritide)
MedicalNewsToday - Fri, 02 Jun 2006 06:00 EST
- Investigators Report Findings Of A Phase 2 Pilot Study Evaluating Postoperative Renal Effects In Heart Failure Patients Treated With Nesiritide
MedicalNewsToday - Thu, 11 May 2006 06:00 EST
- Heart failure drug, Nesiritide, associated with higher risk of death
MedicalNewsToday - Wed, 20 Apr 2005 04:00 EST

Not Signed In -

